Semin Thromb Hemost 2001; 27(2): 149-154
DOI: 10.1055/s-2001-14074
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Clinical Study of Venous Thromboembolism during Pregnancy and Puerperium

Tomoko Adachi1 , Kazunari  Hashiguchi2 , Yoshimi Arai1 , Hiroaki Ohta1
  • 1Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Tokyo, Japan and
  • 2Maternal and Perinatal Center, Tokyo Women's Medical University, Tokyo, Japan
Further Information

Publication History

Publication Date:
31 December 2001 (online)

ABSTRACT

We encountered 16 cases of venous thromboembolism (VTE) in women during pregnancy and/or puerperium over the past 15 years at our perinatal center, representing 0.14% of all patients who delivered babies. The present study was undertaken to analyze the risk factors, clinical course and outcomes in these 16 cases. The ages of the patients varied from 29 to 39 years. Four women had pulmonary embolism (PE), 3 of which after caesarean section (C/S) at 35 to 40 weeks, and one case after ovarian cystectomy at 13 weeks of gestation. Twelve cases had deep venous thrombosis (DVT), 4 of which during pregnancy, and the remaining 8 cases after C/S. Four patients who had DVT during a normal course of pregnancy had severe thrombophilia: antiphospholipid antibody syndrome, a history of thrombosis and antithrombin (AT) deficiency. They were treated with heparin with or without AT and had healthy babies via successful vaginal deliveries. The common risk factors in 3 cases of PE with C/S was prolonged bed rest due to threatened premature delivery with total placenta previa, uterine myoma and Ehlers-Danlos syndrome. Other risk factors were massive bleeding, and positive lupus anticoagulant. However, the case of the ovarian cystectomy had only one risk factor, which was obesity. This patient died but the remaining patients recovered with treatment. Because of the low incidence of thrombosis in the Japanese population, prophylactic anticoagulant therapy has not routinely been given to patients undergoing obstetrical operations. However, proper management including prophylactic anticoagulant therapy might be considered for risk patients, depending on the risk factors.

REFERENCES

  • 1 Hirsh J, Genton E. Thrombogenesis. In: Root WS, Hofman FG, eds. Physiological Pharmacology: A Comprehensive Treatise New York: Academic Press 1974: 99-133
  • 2 Wessler S, Yin E T. On the mechanism of thrombosis.  Prog Hematol . 1969;  6 201-232
  • 3 Davies G S, Salzman E W. The pathogenesis of deep vein thrombosis. In: Joist HJ, Sherman LA, eds. Venous and Arterial Thrombosis: Pathogenesis, Diagnosis, Prevention, and Therapy New York: Grune & Stratton 1979: 1-22
  • 4 Francis R G. Increased intravascular coagulation associated with pregnancy.  Obstet Gynecol . 1990;  75 385-389
  • 5 LeQuesne L P. Relation between deep vein thrombosis and pulmonary embolism in surgical patients.  N Engl J Med . 1974;  291 1292-1294
  • 6 Adachi T, Nakabayashi M, Takeda Y. Management of venous thrombosis and pulmonary embolism after gynecological surgery.  Semin Thromb Hemost . 1998;  24 437-442
  • 7 Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals from the council on thrombosis.  Circulation. . 1996;  93 2212-2245
  • 8 Harris E N. Antiphospholipid antibodies.  Br J Haematol . 1990;  74 1-9
  • 9 Broekmans A W, Veltkamp J J. Congenital protein C deficiency and venous thromboembolism.  N Engl J Med . 1983;  309 340-344
  • 10 Comp P C, Esmon C T. Recurrent venous thromboembolism in patients with a partial deficiency of protein S.  N Engl J Med . 1984;  311 1525-1528
  • 11 Strandness Jr E D, Ward K, Krugmire Jr R. The present status of acute deep venous thrombosis.  Surg Gynecol Obstet . 1977;  145 433-445
  • 12 De Stefano V, Finazzi G, Mannucci P M. Inherited thrombophilia: pathogenesis, clinical syndromes and management.  Blood . 1996;  87 3531-3544
  • 13 Halbmayer W M, Haushover A, Schon R. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects.  Blood Coagul Fibrinolysis . 1994;  5 51-57
  • 14 Ginsberg J S, Brill-Edwards P, Burrows R F. Venous thrombosis during pregnancy: leg and trimester of presentation.  Thromb Haemost . 1992;  67 519-520
  • 15 Kusama T. Pregnancy and radiology (in Japanese).  J Jpn Med Assoc. 2000;  127 367-374
  • 16 Büller H R, Lensing A WA, Hirsh J, ten Cate W J. Deep venous thrombosis: new noninvasive tests.  Thromb Haemost . 1991;  66 133-137
  • 17 Foley W D, Middleton W D, Lawson T L. Color Doppler ultrasound imaging of lower-extremity venous disease.  AJR . 1989;  152 371-376
  • 18 Baxter G M, McKechnie S, Duffy P. Colour Doppler ultrasound in deep venous thrombosis: a comparison with venography.  Clin Radiol . 1990;  42 32-36
  • 19 Ginsberg J S, Hirsh J, Turner D C, Levine M N, Burrows R. Risks to the fetus of anticoagulant therapy during pregnancy.  Thromb Haemost. 1989;  61 197-203
  • 20 McKenna R, Cole E R, Vasan U. Is warfarin sodium contraindicated in the lactating mother?.  J Pediatr . 1983;  103 325-327
  • 21 Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy.  Acta Obst Gynaecol Scand . 1983;  62 239-243
  • 22 Kakkar V V. Effectiveness and safety of low molecular weight heparins (LMWH) in the prevention of venous thromboembolism (VTE).  Thromb Haemost . 1995;  74 364-368
  • 23 Sawayama T. Thromboembolism of pulmonary artery (in Japanese).  J Jpn Coll Angiol. 1993;  33 397-398
  • 24 Murata S, Ino T, Adachi H. An emergent surgical case of acute massive pulmonary embolism supported by antithrombotic percutaneous cardiopulmonary support system (in Japanese).  J Jpn Assoc Thorac Surg. 1997;  45 1159-1164
    >